Stryker Orthopaedics
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Stryker Orthopaedics sits in the top decile of US sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count).
Stryker Orthopaedics: 27 sponsored US clinical trials, 1 recruiting.
Stryker Orthopaedics sponsors 27 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 10 completed. The most-studied condition in this pipeline is Replacement, with 2 trials.
Top-decile sponsor footprint
Stryker Orthopaedics ranks in the top decile of sponsors by registered trial count (#583 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
10 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (47.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
27 total, page 1 of 1
Restoration Anatomic Acetabular Shell Revision Study
NCT05591859
Insignia™ Hip Stem Outcomes Study
NCT05144191
Triathlon All-Polyethylene Tibia Outcomes Study
NCT04636190
Trident II Tritanium Acetabular Shell Outcomes Study
NCT02999009
Triathlon Tritanium Cone Augments Outcomes Study
NCT02521103
Mako-MORE Registry
NCT07647354
Triathlon PSR Outcomes Study
NCT04618770
Trident II Revision Outcomes Study
NCT04317586
Triathlon Tritanium Knee Outcomes Study
NCT02155712
Secur-Fit Advanced Outcomes Study
NCT01917929
Tritanium® Primary Acetabular Shell Study
NCT01063751
Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study
NCT01420237
Pelvic Alignment Level (PAL) Instrument Evaluation
NCT01312428
Rejuvenate Modular Outcomes Study
NCT01257568
A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device
NCT01270919
Triathlon® Partial Knee Replacement (PKR) Outcomes Study
NCT00966979
Triathlon Total Stabilizer (TS) Outcomes Study
NCT00958789
LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study
NCT00510458
Trident® Tritanium™ Acetabular Shell Revision Study
NCT00535626
Accolade® TMZF® Hip Stem Outcomes Study
NCT00957658
Triathlon® Posteriorly Stabilized (PS) Total Knee System - Outcomes Study
NCT00957021
Trident® X3 Polyethylene Insert Study
NCT00958191
Triathlon® Cruciate Retaining (CR) Total Knee System Outcomes Study
NCT00957723
Restoration® Modular Revision Hip System Post Market Study
NCT00962013
ABC/Trident® Ceramic Post Approval Study
NCT00960206
Scorpio® Cruciate Retaining (CR) Outcomes Study
NCT00965146
Omnifit Hydroxylapatite (HA) Hip Outcomes Study
NCT00958347
What is open in the Stryker Orthopaedics pipeline
1 recruiting of 27 indexed (4% open); 10 completed (37%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Replacement (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Stryker Orthopaedics: open-pipeline peers nationwide
Peers matched on 27 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Stryker Orthopaedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 27 trials (± recruiting share)
- Akron Children's Hospital · 27 trials · 7% recruiting
- ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) · 27 trials · 0% recruiting
- AVEO Pharmaceuticals · 27 trials · 7% recruiting
- Dompé Farmaceutici S.p.A · 27 trials · 15% recruiting
Sponsors near 4% open enrollment (± trial volume)
- US Oncology Research · 4% recruiting · 27 trials
- GlaxoSmithKline · 4% recruiting · 1,345 trials
- Otsuka Pharmaceutical Development & Commercialization · 4% recruiting · 221 trials
- Teva Branded Pharmaceutical Products R&D · 4% recruiting · 167 trials
Related
What to do with this Stryker Orthopaedics page
27 registered trials is a research-attention snapshot, not an endorsement of Stryker Orthopaedics or any single study.
- 1 of Stryker Orthopaedics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Replacement is the condition Stryker Orthopaedics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Replacement trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Stryker Orthopaedics pipeline card: 27 registered trials from official public datasets.Report a data error.